MEDIMMUNE VACCINES, INC. – Trademark Portfolio
Entity Type: 03
MEDIMMUNE VACCINES, INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FLUMIST. The owner is based in Mountain View, CA.
297 North Bernardo Avenue
Mountain View, CA 94043
Showing of trademarks Trademarks
Trademark Classifications
MEDIMMUNE VACCINES, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does MEDIMMUNE VACCINES, INC. have?
MEDIMMUNE VACCINES, INC. has 19 U.S. trademarks filed with the USPTO. Of these, 1 registered, 13 abandoned, 5 cancelled.
What trademark classes does MEDIMMUNE VACCINES, INC. file in?
MEDIMMUNE VACCINES, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods), Class 11 (Environmental Control). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MEDIMMUNE VACCINES, INC.'s most well-known trademarks?
MEDIMMUNE VACCINES, INC.'s registered trademark portfolio includes well-known marks such as FLUMIST. These are among 1 currently registered trademark in the portfolio.
What is MEDIMMUNE VACCINES, INC.'s trademark registration success rate?
MEDIMMUNE VACCINES, INC. has a 5% trademark registration rate, with 1 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.